{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:01:37Z","timestamp":1782205297467,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To describe the use of inotropic drugs and the characteristics of neonates receiving such treatment in a national cohort of patients admitted to neonatal ICUs in Norway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>A national registry study of patients included in the Norwegian Neonatal Network database 2009\u20132014. Demographic and treatment data, including the use of inotropic drugs (dopamine, dobutamine, epinephrine, norepinephrine, milrinone, and levosimendan) and outcomes, were retrieved and analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Neonatal ICUs in Norway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>All patients admitted to Norwegian neonatal ICUs 2009\u20132014 with a postmenstrual age of less than 310 days at admission, corresponding to a postnatal age of less than 28 days for a child born at term (<jats:italic toggle=\"yes\">n<\/jats:italic> = 36 397).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Inotropic drugs were administered to 974 of 361,803 live born infants (0.27%) in the study period, representing 2.7% of the neonatal ICU patient population. The relative proportion of neonatal ICU patients receiving inotropes decreased with increasing gestational age, yet 41% of the patients receiving inotropes were born at term. Of note, 89.8% of treated patients received dopamine. Use of inotropes was particularly prevalent in patients with necrotizing enterocolitis (72.4%) and pulmonary hypertension (42.1%) and in patients with gestational age less than 28 weeks (28.2%). Inotropic treatment initiated in the first week of life (84.2%) was associated with birth asphyxia and pulmonary hypertension, whereas treatment initiated after the first week of life was associated with extremely preterm birth, neonatal surgery, neonatal sepsis, cardiac disease, and necrotizing enterocolitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This comprehensive epidemiologic study indicates that less than 0.3% of newborns receive inotropic support in the neonatal period. Dopamine was the most commonly used drug. Relating inotrope use to clinical condition, gestational age, and postnatal age may be useful for clinicians and helpful in delineating relevant patient populations for future clinical trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000000898","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T16:56:07Z","timestamp":1470761767000},"page":"948-956","source":"Crossref","is-referenced-by-count":34,"title":["Inotropic Therapy in Newborns, A Population-Based National Registry Study*"],"prefix":"10.1097","volume":"17","author":[{"given":"Margrete Larsen","family":"Burns","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Oslo University Hospital Ulleval, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J\u00f8rgen","family":"Stensvold","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Oslo University Hospital Rikshospitalet, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Risnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J\u00f8rgen","family":"Guthe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Haukeland University Hospital, Bergen, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Astrup","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital of Southern Norway, Kristiansand, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Marianne","family":"Nordhov","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of North Norway, Troms\u00f8, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje Reidar","family":"Selberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ostfold Hospital Trust, Kalnes, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arild","family":"R\u00f8nnestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astri Maria","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Oslo University Hospital Rikshospitalet, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jpeds.2014.06.009","article-title":"Trends in pharmacotherapy for neonatal hypotension.","volume":"165","author":"Rios","year":"2014","journal-title":"J Pediatr"},{"key":"R2-20230823","first-page":"CD003958","article-title":"Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise.","author":"Paradisis","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"R3-20230823","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/14767058.2011.607565","article-title":"What\u2019s new in the treatment of neonatal shock.","volume":"24","author":"Caresta","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1067\/mpd.2002.120834","article-title":"Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow.","volume":"140","author":"Osborn","year":"2002","journal-title":"J Pediatr"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1542\/peds.2004-1396","article-title":"Cardiovascular support for low birth weight infants and cerebral hemodynamics: A randomized, blinded, clinical trial.","volume":"115","author":"Pellicer","year":"2005","journal-title":"Pediatrics"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/jp.2011.2","article-title":"A meta-analysis of dopamine use in hypotensive preterm infants: Blood pressure and cerebral hemodynamics.","volume":"31","author":"Sassano-Higgins","year":"2011","journal-title":"J Perinatol"},{"key":"R7-20230823","first-page":"CD001242","article-title":"Dopamine versus dobutamine for hypotensive preterm infants.","author":"Subhedar","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20230823","first-page":"CD005090","article-title":"The effect of inotropes on morbidity and mortality in preterm infants with low systemic or organ blood flow.","author":"Osborn","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1542\/peds.2006-3398","article-title":"Low superior vena cava flow and effect of inotropes on neurodevelopment to 3 years in preterm infants.","volume":"120","author":"Osborn","year":"2007","journal-title":"Pediatrics"},{"key":"R10-20230823","first-page":"CD002056","article-title":"Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm infants.","author":"Osborn","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.clinthera.2006.09.006","article-title":"Cardiovascular support in preterm infants.","volume":"28","author":"Evans","year":"2006","journal-title":"Clin Ther"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.siny.2013.09.006","article-title":"Neonatal hypotension: Dopamine or dobutamine?","volume":"19","author":"Gupta","year":"2014","journal-title":"Semin Fetal Neonatal Med"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.jp.7211774","article-title":"Treating hypotension in the preterm infant: When and with what: A critical and systematic review.","volume":"27","author":"Dempsey","year":"2007","journal-title":"J Perinatol"},{"key":"R16-20230823","first-page":"CD003311","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy.","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"F213","DOI":"10.1136\/adc.2005.071829","article-title":"Which inotrope for which baby?","volume":"91","author":"Evans","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R18-20230823","first-page":"CD003484","article-title":"Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia.","author":"Hunt","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jp.7210563","article-title":"Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs.","volume":"21","author":"Al-Aweel","year":"2001","journal-title":"J Perinatol"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.clinthera.2011.11.001","article-title":"Dopamine and dobutamine use in preterm or low birth weight neonates in the premier 2008 database.","volume":"33","author":"Lasky","year":"2011","journal-title":"Clin Ther"},{"key":"R21-20230823","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1542\/peds.2006-1138","article-title":"Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week.","volume":"119","author":"Laughon","year":"2007","journal-title":"Pediatrics"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1440-1754.2011.02246.x","article-title":"Cardiovascular support in preterm infants: A survey of practices in Australia and New Zealand.","volume":"48","author":"Sehgal","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0034-1371703","article-title":"Inotrope use among extremely preterm infants in Canadian neonatal intensive care units: Variation and outcomes.","volume":"32","author":"Wong","year":"2015","journal-title":"Am J Perinatol"},{"key":"R26-20230823","first-page":"440","article-title":"Birthweight by gestational age in Norway.","volume":"79","author":"Skjaerven","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.earlhumdev.2006.09.020","article-title":"Assessment and support of the preterm circulation.","volume":"82","author":"Evans","year":"2006","journal-title":"Early Hum Dev"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000349928","article-title":"European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants\u20132013 update.","volume":"103","author":"Sweet","year":"2013","journal-title":"Neonatology"},{"key":"R29-20230823","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012.","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201610000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T23:09:21Z","timestamp":1692832161000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201610000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000000898","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}